You are here

Clinical Trials: Central Nervous System Diseases

Comment

Discuss

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Wednesday, July 31, 2013 - 12:00
Condition:   Cerebellar Ataxia
Intervention:   Biological: Intravenous transfer of of Bone Marrow derived Mono Nuclear Stem Cell (BMMNCs)
Sponsor:   Chaitanya Hospital, Pune
Recruiting - verified September 2014
Posted: Sunday, May 5, 2013 - 12:00
Condition:   Traumatic Brain Injury
Interventions:   Biological: autologous bone marrow mononuclear cells;   Other: Placebo Infusion
Sponsors:   The University of Texas Health Science Center, Houston;   National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified April 2016
Posted: Thursday, April 11, 2013 - 12:00
Condition:   Huntington Disease
Intervention:   Biological: autologous Stem Cell
Sponsor:   Chaitanya Hospital, Pune
Recruiting - verified September 2014
Posted: Tuesday, April 9, 2013 - 12:00
Condition:   Stroke,
Intervention:   Other: Intra thecal transplantation of Autologous Stem Cells
Sponsor:   Chaitanya Hospital, Pune
Recruiting - verified September 2014
Posted: Monday, April 8, 2013 - 12:00
Condition:   Ataxic Infantile Cerebral Palsy
Intervention:   Biological: stem cell (MNCs )
Sponsor:   Chaitanya Hospital, Pune
Recruiting - verified September 2014
Posted: Tuesday, February 26, 2013 - 12:00
Condition:   Cerebral Palsy
Intervention:   Other: Intra thecal inj of autologous MNC
Sponsor:   Chaitanya Hospital, Pune
Recruiting - verified September 2014
Posted: Tuesday, February 26, 2013 - 12:00
Condition:   Spinal Cord Injury.
Intervention:   Biological: Transplantation of Autologous stem cell [MNCs] .
Sponsor:   Chaitanya Hospital, Pune
Recruiting - verified September 2014
Posted: Tuesday, January 15, 2013 - 12:00
Condition:   Spinal Cord Injury
Intervention:   Procedure: Autologous Adipose Tissue derived MSCs Transplantation
Sponsors:   Biostar;   Korea University Anam Hospital
Recruiting - verified March 2014
Posted: Monday, January 14, 2013 - 12:00
Condition:   Spinal Cord Injury (SCI)
Intervention:   Drug: Human spinal cord stem cells.
Sponsor:   Neuralstem Inc.
Recruiting - verified April 2017
Posted: Thursday, October 25, 2012 - 12:00
Condition:   Stroke, Ischemic
Intervention:   Other: Mesenchymal stem cell
Sponsors:   Samsung Medical Center;   Pharmicell Co., Ltd.
Recruiting - verified May 2014

Pages